alexa Cardiovascular Risk in Rheumatoid Arthritis. An Update for General Practitioners | OMICS International| Abstract

Cardiovascular Therapy: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Cardiovasc Ther 2016, Vol 1(2): 109

Cardiovascular Risk in Rheumatoid Arthritis. An Update for General Practitioners

Cocco Giuseppe1*, Amiet Philipp2 and Jerie Paul1
1Cardiology Office, , Marktgasse, Rheinfelden, Switzerland
2Medical Office, , Schiffackerweg, Rheinfelden, Switzerland
*Corresponding Author : Cocco Giuseppe, Cardiology Office, Marktgasse 10 A, CH-4310 Rheinfelden, Switzerland, Tel: 061 83145 55, Email: [email protected]

Received Date: Jun 02, 2016 / Accepted Date: Jun 09, 2016 / Published Date: Jun 16, 2016

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory articular pathology which affects almost 1% of the general population and which is ranked among the top 15% of diseases causing major disability worldwide. RA shares some pathologic features, genetic predisposition and risk factors with atherosclerosis. Inflammation plays a central pathophysiologic role in both diseases. As compared with the general population, in RA the prevalence of cardiovascular events is increased to an extent comparable to that of type 2 diabetes mellitus. RA-Patients have a higher incidence of myocardial ischemia and infarction, cardiac failure, valvular heart disease, pericarditis, myocarditis and, to a lesser extent, venous complications. The occurrence of sudden cardiac death is two-fold increased and that of major adverse cardiovascular events is augmented to almost 50%. Cardiovascular deaths increase seven years following symptoms onset. Control of the joint pathology remains the principal therapeutic aim in RA, but the impact of cardiovascular complications should not be forgotten. Patients with RA who are at high cardiovascular risk should be given the best available therapies to reduce the cardiovascular complications. There are things we know that we know. There are known unknowns. That is to say, there are things that we know that we don’t know. But there are also unknown unknowns. There are things we don’t know we don’t know. Donald Rumsfeld

Keywords: Rheumatoid arthritism; Cardiovascular risks; Pathology; Heart disease; Venous complications

Citation: Giuseppe C, Philipp A, Paul J (2016) Cardiovascular Risk in Rheumatoid Arthritis. An Update for General Practitioners. Cardiovasc Ther 1: 109.

Copyright: © 2016 Giuseppe C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 10629
  • [From(publication date): 7-2016 - Nov 24, 2020]
  • Breakdown by view type
  • HTML page views: 10428
  • PDF downloads: 201
Top